sorafenib has been researched along with rifamycin sv in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (rifamycin sv) | Trials (rifamycin sv) | Recent Studies (post-2010) (rifamycin sv) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 434 | 10 | 50 |
| Protein | Taxonomy | sorafenib (IC50) | rifamycin sv (IC50) |
|---|---|---|---|
| Bile salt export pump | Rattus norvegicus (Norway rat) | 3.1 | |
| Bile salt export pump | Homo sapiens (human) | 7.9 | |
| DNA-directed RNA polymerase subunit beta | Escherichia coli K-12 | 0.025 | |
| DNA-directed RNA polymerase subunit beta | Shigella sonnei Ss046 | 0.025 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
1 other study(ies) available for sorafenib and rifamycin sv
| Article | Year |
|---|---|
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |